Pediatric Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV 2) and Potential Health Policy Consequences
Background: COVID-19, the disease caused by SARS-CoV-2 infection, is milder in children than in adults. Infected children and adolescents are at lower risk of hospitalization or experiencing severe morbidity or mortality than adults, especially the elderly. However, there are many unanswered questions regarding the overall impact of COVID-19 in children that require further inquiry and discussion, some of which will be addressed in this forum. These include short-and long-term outcomes of SARS-CoV-2 infection in children, as well as the safety and efficacy of COVID-19 vaccines and therapeutics. The impact of pediatric infection on contacts of affected children, both at school and at home, will be discussed. Public health and public policy considerations will be explored. Future directions for mitigating the impacts of COVID-19 in children will be considered.
Objectives: In this International Society for Pharmacoepidemiology Conference, the objectives are to 1) discuss the multiple facets of SARS-CoV-2 infection in children; 2) discuss the strengths and limitations of the current approach to management of COVID-19, from both a clinical and societal viewpoint; and 3) identify areas where additional research is needed.